During the past decade, Bonheiden - HOSP Imelda conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bonheiden - HOSP Imelda" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bonheiden - HOSP Imelda" are "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Nephropathies" (1 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "Bonheiden - HOSP Imelda" in a lesser frequency.

Most popular intervention types in "Bonheiden - HOSP Imelda" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Dabigatran Etexilate 150mg" (2 trials), "Empagliflozin" (2 trials), "Placebo" (2 trials), "Aspirin" (1 trials) and "BI 685509" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bonheiden - HOSP Imelda" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Bonheiden - HOSP Imelda". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bonheiden - HOSP Imelda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bonheiden - HOSP Imelda, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".